VivoTex offers 3D printed microfiber scaffolds designed to help researchers replicate tissue models more effectively than other scaffolds, matrices, or bioinks. Our proprietary melt electrowriting (MEW) technology—a cutting-edge 3D printing technique—creates highly precise, customizable scaffolds at the human cellular scale. This innovative process provides enhanced control over the cell micro-environment, accelerating cell growth, improving cell-to-cell communication, and boosting viability. Ideal for in vitro tissue engineering, cancer research, and drug discovery, customers may choose from a catalog of application-specific scaffolds or work with our engineering team to create a custom-designed solution that meets their study needs.
| Website | https://www.vivotex.com |
| Employees | 9 (6 on RocketReach) |
| Founded | 2024 |
| Industry | Biotechnology Research |
Looking for a particular VivoTex employee's phone or email?
Ievgenii Liashenko is the Founder and CTO of VivoTex.
6 people are employed at VivoTex.
VivoTex is based in Newberg, Oregon.